A Phase 1/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamis and Efficacy of VT-464 in Patients with Advanced Breast Cancer - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 1/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamis and Efficacy of VT-464 in Patients with Advanced Breast Cancer

Type of Cancer
Breast Oncology
Locations
Hackensack
Sponsor
Innocrin
Protocol Number
INO-VT-464-CL-006
Cancer Diagnosis
To Learn More Call
201-510-0910